Sponsor:
Christiana Care Health Services
Code:
NCT07664956
Conditions
Minimally Invasive Surgical Procedures
Abnormal Uterine Bleeding, Unspecified
Adenomyosis of Uterus
Fibroid Uterus
Chronic Pelvic Pain
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cyclobenzaprine
Brief summary:
Conditions
Minimally Invasive Surgical Procedures
Abnormal Uterine Bleeding, Unspecified
Adenomyosis of Uterus
Fibroid Uterus
Chronic Pelvic Pain
Study ID
NCT07664956
Start date
Sep 1, 2026
Status verified date
Nov, 2026
Completion date
May 1, 2027
Anticipated
Primary completion date
May 1, 2027
Anticipated
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
36 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
no intervention: Control
experimental: Cyclobenzaprine
Interventions
Cyclobenzaprine
Primary outcome measure
Central contacts
Locations
ChristianaCare Health System
Recruiting
Newark, Delaware, United States, 19718
Sponsor
Christiana Care Health Services
Last update posted
Nov 20, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-21. This information was provided to ClinicalTrials.gov by Christiana Care Health Services on 2026-11-20. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.